134 related articles for article (PubMed ID: 16689355)
1. [Androgens and androgen receptor in prostate cancer].
Miyoshi Y; Kubota Y
Nihon Rinsho; 2006 Apr; 64 Suppl 4():489-93. PubMed ID: 16689355
[No Abstract] [Full Text] [Related]
2. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
[TBL] [Abstract][Full Text] [Related]
3. [Androgen receptor].
Komori S; Yamamoto N; Takenobu T
Nihon Rinsho; 2006 Apr; 64 Suppl 4():471-6. PubMed ID: 16689352
[No Abstract] [Full Text] [Related]
4. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
5. Expression of androgen receptor coactivators in normal and cancer prostate tissues and cultured cell lines.
Mestayer C; Blanchère M; Jaubert F; Dufour B; Mowszowicz I
Prostate; 2003 Aug; 56(3):192-200. PubMed ID: 12772188
[TBL] [Abstract][Full Text] [Related]
6. [The mechanism and predictive factors of hormone-independent recurrence of prostate cancer].
Tomita K; Kitamura T
Nihon Rinsho; 2002 Dec; 60 Suppl 11():70-5. PubMed ID: 12599548
[No Abstract] [Full Text] [Related]
7. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
Agoulnik IU; Vaid A; Bingman WE; Erdeme H; Frolov A; Smith CL; Ayala G; Ittmann MM; Weigel NL
Cancer Res; 2005 Sep; 65(17):7959-67. PubMed ID: 16140968
[TBL] [Abstract][Full Text] [Related]
8. p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6.
Debes JD; Comuzzi B; Schmidt LJ; Dehm SM; Culig Z; Tindall DJ
Cancer Res; 2005 Jul; 65(13):5965-73. PubMed ID: 15994976
[TBL] [Abstract][Full Text] [Related]
9. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
Heemers HV; Regan KM; Dehm SM; Tindall DJ
Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004
[TBL] [Abstract][Full Text] [Related]
10. The androgen receptor gene and its influence on the development and progression of prostate cancer.
Montgomery JS; Price DK; Figg WD
J Pathol; 2001 Sep; 195(2):138-46. PubMed ID: 11592091
[TBL] [Abstract][Full Text] [Related]
11. [Androgen receptor].
Komiya A; Ito H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():476-80. PubMed ID: 16149555
[No Abstract] [Full Text] [Related]
12. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
Palmberg C; Koivisto P; Kakkola L; Tammela TL; Kallioniemi OP; Visakorpi T
J Urol; 2000 Dec; 164(6):1992-5. PubMed ID: 11061898
[TBL] [Abstract][Full Text] [Related]
13. Alterations of androgen receptor in prostate cancer.
Linja MJ; Visakorpi T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):255-64. PubMed ID: 15663988
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
Koivisto P; Kononen J; Palmberg C; Tammela T; Hyytinen E; Isola J; Trapman J; Cleutjens K; Noordzij A; Visakorpi T; Kallioniemi OP
Cancer Res; 1997 Jan; 57(2):314-9. PubMed ID: 9000575
[TBL] [Abstract][Full Text] [Related]
15. The development of androgen-independent prostate cancer.
Feldman BJ; Feldman D
Nat Rev Cancer; 2001 Oct; 1(1):34-45. PubMed ID: 11900250
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.
Taplin ME; Balk SP
J Cell Biochem; 2004 Feb; 91(3):483-90. PubMed ID: 14755679
[TBL] [Abstract][Full Text] [Related]
17. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor.
Chesire DR; Isaacs WB
Oncogene; 2002 Dec; 21(55):8453-69. PubMed ID: 12466965
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.
Truica CI; Byers S; Gelmann EP
Cancer Res; 2000 Sep; 60(17):4709-13. PubMed ID: 10987273
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
[TBL] [Abstract][Full Text] [Related]
20. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
